Bharat Biotech's nasal vax priced at Rs 800 for private markets

Bharat Biotech International Limited on Tuesday said its COVID-19 intranasal vaccine iNCOVACC, which is now available on CoWIN portal, is priced at Rs 800 (excluding GST) for private markets and Rs......

'Big Boost': Bharat Biotech's nasal vaccine against Covid cleared for use

The Drugs Controller General of India (DCGI) on Tuesday approved Bharat Biotech's intranasal Covid vaccine for restricted emergency use in those aged above 18 years. "Big Boost to India's Fight......

Bharat Biotech completes phase-III trials for nasal Covid vaccine

Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, and it has proven to be safe. Photograph:......

Bharat Biotech's nasal Covid vaccine iNCOVACC launched

Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech's nasal Covid vaccine, iNCOVACC, on the occasion of Republic Day on Thursday.......

Bharat Biotech starts Covaxin's at-risk manufacture

The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results, reports Sohini Das. Photograph: Kind courtesy Bharat Biotech  ......

What's behind Bharat Biotech's Zika 'hype'?

Bharat Biotech started work on developing a vaccine against Zika way back in 2014, but the timing of its announcement has created a flutter in the market. When Bharat Biotech recently......

Meet the man behind India's Genome Valley

This is the amazing story of Dr Krishna M Ella, a scientist who turned into a serial entrepreneur. Krishna Ella, chairman and managing director of Bharat Biotech International Ltd, is one of the......

India set to be global clinical trials hub

India is emerging as a major hub for global clinical trials and this new sector is poised to generate more revenue than the information technology industry by 2010, an industry leader has......